Glucotrack, Inc.
GCTK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001506983
No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Glucotrack, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 38.5K | +38.5K |
| Value | $0 | $161.0K | +$161.0K |
New holders (3)
Institutions that held Glucotrack, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boston Financial Mangement LLC | 26,372 | $110.0K | 0.00% |
| Susquehanna International Group, LLP | 11,434 | $48.0K | 0.00% |
| UBS Group AG | 684 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Glucotrack, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.